Kazunori Toyoda Selected Research

Rivaroxaban

1/2022	Early initiation of rivaroxaban after reperfusion therapy for stroke patients with nonvalvular atrial fibrillation.
1/2022	Bridging Therapy With Heparin Before Starting Rivaroxaban in Ischemic Stroke or Transient Ischemic Attack With Non-Valvular Atrial Fibrillation.
7/2021	ASPECTS-Region-Dependent Functional Outcomes after Endovascular Therapy in Patients with Cardioembolic Stroke.
4/2021	Sex Differences in Management and Outcomes of Cardioembolic Stroke: Post HOC Analyses of the RELAXED Study.
12/2019	Branch atheromatous disease diagnosed as embolic stroke of undetermined source: A sub-analysis of NAVIGATE ESUS.
1/2019	Rivaroxaban administration after acute ischemic stroke: The RELAXED study.
1/2019	Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.
1/2019	Rivaroxaban concentrations in acute stroke patients with different dosage forms.
10/2018	Anti-Xa Activity and Event Risk in Patients With Direct Factor Xa Inhibitors Initiated Early After Stroke.
7/2016	Intracranial subdural hematomas with elevated rivaroxaban concentration and subsequently detected spinal subdural hematoma: A case report.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazunori Toyoda Research Topics

Disease

173	Stroke (Strokes) 10/2022 - 01/2004
105	Ischemic Stroke 07/2022 - 05/2003
49	Hemorrhage 10/2022 - 09/2004
44	Atrial Fibrillation 07/2022 - 01/2009
42	Cerebral Hemorrhage 10/2022 - 11/2004
16	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022 - 01/2004
16	Embolism (Embolus) 01/2022 - 07/2004
16	Infarction (Infarctions) 01/2022 - 01/2004
15	Hypertension (High Blood Pressure) 01/2021 - 01/2004
14	Hematoma 10/2022 - 05/2003
14	Transient Ischemic Attack 01/2022 - 08/2015
14	Embolic Stroke 01/2022 - 02/2014
7	Atherosclerosis 02/2021 - 07/2007
7	Thrombosis (Thrombus) 07/2018 - 01/2002
6	Hemorrhagic Stroke 01/2022 - 06/2008
6	Body Weight (Weight, Body) 01/2022 - 11/2014
6	Myocardial Infarction 10/2021 - 01/2017
5	Pathologic Constriction (Stenosis) 07/2022 - 01/2006
5	COVID-19 07/2022 - 01/2020
5	Cerebral Infarction 01/2022 - 06/2016
4	Thrombocytopenia (Thrombopenia) 01/2022 - 01/2008
4	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2022 - 07/2010
4	Infections 01/2020 - 01/2015
4	Diabetes Mellitus 04/2018 - 01/2006
3	Hyperglycemia 04/2022 - 11/2009
3	Epilepsy (Aura) 01/2021 - 03/2014
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2020 - 06/2008
3	Venous Thrombosis (Deep-Vein Thrombosis) 01/2019 - 04/2012
3	Aortic Dissection 08/2018 - 01/2015
3	Heart Failure 01/2018 - 11/2009
3	Carotid Artery Diseases 01/2018 - 07/2007
3	Paresis (Hemiparesis) 08/2016 - 09/2005
3	Ischemia 01/2016 - 02/2011
3	Thromboembolism 12/2015 - 01/2012
2	Neoplasms (Cancer) 05/2022 - 01/2022
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 02/2022 - 01/2004
2	Albuminuria 01/2022 - 02/2009
2	Peripheral Arterial Disease 10/2021 - 01/2020
2	Aneurysm (Aneurysms) 08/2021 - 05/2005
2	Chronic Renal Insufficiency 10/2020 - 08/2014
2	Aortic Aneurysm (Aneurysm, Aortic) 01/2020 - 09/2014
2	Venous Thromboembolism 01/2020 - 01/2019
2	Atrophy 01/2019 - 01/2006
2	Moyamoya Disease (Moya-Moya Disease) 01/2019 - 05/2014
2	Carotid Stenosis (Carotid Artery Stenosis) 01/2019 - 07/2004
2	Brain Infarction 01/2019 - 05/2003

Drug/Important Bio-Agent (IBA)

53	AnticoagulantsIBA 07/2022 - 05/2003
47	Tissue Plasminogen Activator (Alteplase)FDA Link 03/2022 - 01/2009
24	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 06/2008
23	Antihypertensive Agents (Antihypertensives)IBA 10/2022 - 11/2003
14	RivaroxabanIBA 01/2022 - 01/2013
13	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2022 - 01/2009
13	Clopidogrel (Plavix)FDA Link 07/2022 - 02/2015
11	Vitamin K FDA Link 01/2022 - 04/2012
10	Nicardipine (Dagan)FDA LinkGeneric 10/2022 - 01/2012
10	fibrin fragment D (D-dimer)IBA 05/2022 - 01/2010
9	Dabigatran FDA Link 01/2022 - 04/2012
9	Biomarkers (Surrogate Marker)IBA 05/2021 - 01/2015
8	CreatinineIBA 01/2022 - 01/2006
8	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 01/2008
8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 04/2010
7	Cilostazol (Pletal)FDA LinkGeneric 07/2022 - 02/2015
7	Indicators and Reagents (Reagents)IBA 01/2021 - 06/2004
7	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2021 - 06/2008
6	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2022 - 06/2008
5	Hemoglobins (Hemoglobin)IBA 07/2021 - 01/2006
5	Prasugrel Hydrochloride FDA Link 02/2021 - 04/2018
4	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 07/2022 - 02/2015
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2008
4	Blood Glucose (Blood Sugar)IBA 12/2018 - 01/2009
4	apixabanIBA 10/2018 - 01/2016
3	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 04/2013
3	Pharmaceutical PreparationsIBA 02/2022 - 07/2013
3	recombinant FVIIa (rFVIIa)FDA Link 01/2022 - 01/2021
3	Thrombin FDA Link 01/2022 - 11/2020
3	LipidsIBA 10/2021 - 01/2012
3	Factor Xa InhibitorsIBA 01/2021 - 04/2012
3	Hemostatics (Antihemorrhagics)IBA 01/2021 - 01/2016
3	Pravastatin (Pravachol)FDA LinkGeneric 01/2019 - 03/2017
3	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 08/2016 - 01/2012
2	FibrinIBA 05/2022 - 01/2018
2	Cytochrome P-450 CYP2C19IBA 03/2022 - 01/2019
2	Factor VIIa (Activated Factor VII)IBA 01/2022 - 01/2021
2	Brain Natriuretic Peptide (Natrecor)FDA Link 08/2021 - 05/2014
2	Biological ProductsIBA 01/2021 - 01/2008
2	CalciumIBA 01/2021 - 07/2013
2	Tranexamic Acid (AMCA)FDA Link 01/2021 - 01/2021
2	CollagenIBA 03/2019 - 02/2016
2	idarucizumabIBA 10/2018 - 09/2018

Therapy/Procedure

104	Therapeutics 07/2022 - 05/2003
26	Thrombectomy 07/2022 - 01/2014
14	Secondary Prevention 10/2021 - 01/2009
6	Carotid Endarterectomy 01/2020 - 10/2005
6	Renal Dialysis (Hemodialysis) 03/2018 - 01/2004
5	Thrombolytic Therapy 04/2016 - 01/2002
4	Drug Therapy (Chemotherapy) 01/2016 - 01/2009
3	Catheter Ablation 01/2022 - 12/2019
3	Stents 01/2021 - 06/2015
3	Aftercare (After-Treatment) 01/2019 - 01/2013
3	Treatment Delay 08/2016 - 11/2014